Skip to main content

Malignant melanoma of the eye

  • Chapter
Clinical Management of Melanoma

Part of the book series: Developments in Oncology ((DION,volume 5))

  • 37 Accesses

Abstract

From the time they begin training, most ophthalmologists are taught and believe that any pigmented lesion about the eye or its adnexa, including the conjunctiva and the skin of the lids, is suspect and should be observed frequently. Although these lesions may represent nevi, melanocytomas or other benign pigment disturbances, the ophthalmologist is all too aware of the potential malignancy of these lesions and their consequences. Exactly what mechanisms cause the alteration of normal pigment-producing cells to become malignant is poorly understood at best, and what causes some normal cells to become more malignant in their activity than others is suspect. Furth [1], in 1961, outlined the possible etiologic factors as being: A) genetic factors, B) hormones and C) carcinogens, agents that initiate modifications of nucleic acid causing loss of proper response to homeostatic regulators. Many investigators believe that viruses may be among the most potent of the carcinogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Furth J: Vistas in the etiology and pathogenesis of tumors. Fed Proc Fed Am Soc Exp 20:865–873, 1961.

    CAS  Google Scholar 

  2. Hogan MJ: Clinical aspects management, and prognosis of melanomas of the uvea and optic nerve. In: Boniuk B (ed) Ocular and Adnexal Tumors. CV Mosby, St.Louis, 1964.

    Google Scholar 

  3. Spencer WH: Discussion in Reese AB: congenital melanomas. Trans Am Ophthalmol Soc 71:186–192, 1973.

    Google Scholar 

  4. Reese A: Tumors of the Eye, 3rd ed. Harper & Row, Hagerstown, 1976.

    Google Scholar 

  5. Rones B and Zimmerman LE: The prognosis of primary tumors of the iris treated by iridectomy. Arch Ophthalmol 60:193–205, 1958.

    Article  CAS  Google Scholar 

  6. Cleasby G: Malignant melanomas of the iris. Arch Ophthalmol 60:403–417, 1958.

    Article  CAS  Google Scholar 

  7. Martin-Jones JD: Uveal sarcomata. Br J Ophthalmol (Supp II):1–94, 1946.

    Google Scholar 

  8. Reese AB: The association of uveal nevi and skin nevi. Trans Am Ophthalmol Soc 49:47–57, 1952.

    Google Scholar 

  9. Bruckner R and Ludin H: Cytodiagnosis of tumors in ophthalmology. Ophthalmologica 133:169–175, 1957.

    Article  PubMed  CAS  Google Scholar 

  10. Paul EV, Parnell BL and Fraker M: Prognosis of malignant melanoma of the choroid and ciliary body. Int Ophthalmol Clin 2:387–402, 1962.

    Article  Google Scholar 

  11. Hopkins RE and Carriker RR: Malignant melanoma of the ciliary body. Am J Ophthalmol 45:835–843, 1958.

    PubMed  CAS  Google Scholar 

  12. Tamler E: A clinical study of choroidal nevi: a follow-up report. Arch Ophthalmol 84:29–32, 1970.

    Article  PubMed  CAS  Google Scholar 

  13. Tamler E and Maumenee AE: A clinical study of choroidal nevi. Arch Ophthalmol 62:196–202, 1959.

    Article  CAS  Google Scholar 

  14. Callender GR: Malignant melanotic tumors of the eye: study of histologic type in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36:131–142, 1931.

    Google Scholar 

  15. Flocks M, Gerende JH and Zimmerman LF: The size and shape of malignant melanomas of the choroid and ciliary body in relation to prognosis and histologic characteristics. Trans Am Acad Ophthalmol Otolaryngol 59:740–758, 1955.

    PubMed  CAS  Google Scholar 

  16. McLean IW and Foster WD: Prognostic factors in small malignant melanomas of choroid and ciliary body 95:48–58, 1977.

    CAS  Google Scholar 

  17. Smith LT and Irvine AR: Diagnostic significance of orange pigment accumulation over choroidal tumors. Am J Ophthalmol 76:212–216, 1973.

    PubMed  CAS  Google Scholar 

  18. Kirk H and Petty R: Malignant malanoma of the choroid: a correlation of clinical and histological findings. Arch Ophthalmol 56:843–860, 1956.

    Article  CAS  Google Scholar 

  19. Makley T and Teed R: Unsuspected intraocular malignant melanomas. Arch Ophthalmol 60:475–478, 1958.

    Article  Google Scholar 

  20. Thomas C, Krohmer M and Storaasli J: Detection of intraocular tumors with radioactive phosphorus. Arch Ophthalmol 47:276, 1952.

    Article  CAS  Google Scholar 

  21. Zakov ZN, Cook SA, Albert DM and Weichselbaum RR: False-positive phosphorus-32 uptake tests in the diagnosis of ocular melanoma, In: Albert and Weichselbaum (eds) International Ophthalmology Clinics (advances regarding the pathogenesis and treatment of ocular tumors), pp 117–121. Little, Brown, Boston, 1980.

    Google Scholar 

  22. Ossoinig K: Standardized echography: Basic principles, clinical applications and results. In: Albert and Weichselbaum (eds) International Ophthalmology Clinics (Advances regarding the pathogenesis and treatment of ocular tumors), pp 127–210. Little, Brown, Boston, 1980.

    Google Scholar 

  23. Gass JDM: Differential Diagnosis of Intraocular Tumors. CV Mosby, St. Louis, 1974.

    Google Scholar 

  24. Zimmerman LE, McLean IW and Foster WD: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 62:420–425, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Fraunfelder FT, Boozman FW, Wilson RS and Thomas AH: No-touch technique for intraocular malignant melanomas. Arch Ophthalmol 95: 1616–1620, 1977.

    Article  PubMed  CAS  Google Scholar 

  26. Apple DJ and Blodi FC: Uveal melanocytic tumors: a grouping according to phases of growth and prognosis with comments on current theories of nonenucleation treatment. In: Albert and Weichselbaum (eds) International Ophthalmology Clinics (Advances regarding the pathogenesis and treatment of ocular tumors), pp 33–61. Little, Brown, Boston, 1980.

    Google Scholar 

  27. Vogel MH: Treatment of malignant choroidal melanomas with photocoagulation. Evaluation of ten year follow-up data. Am J Ophthalmol 74:1, 1972.

    PubMed  CAS  Google Scholar 

  28. Shields JA, Annesley WH, Jr, Federman JL et al: Fluoroscrein and 32P studies in photocoagulated melanomas. Presented at First International Photocoagulation Congress, New York, September, 1975. CV Mosby, St. Louis, 1976.

    Google Scholar 

  29. Stallard HB: Malignant melanoblastoma of the choroid. Mod Probl Ophthalmol 7:16, 1968.

    Google Scholar 

  30. Constable I: Proton irradiation for small malignant melanomas of the choroid. In: Brockhurst, Boruchoff, Hutchinson and Lessell (eds) Controversy in Ophthalmology, pp 626–634. WB Saunders, Philadelphia, 1977.

    Google Scholar 

  31. Packer S and Rothman M: Radiotherapy of choroidal melanoma with iodine 125, In: Albert and Weichselbaum (eds) International Ophthalmology Clinics (Advances regarding the pathogenesis and treatment of ocular tumors), pp 135–142. Little, Brown, Boston, 1980.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague/Boston/London

About this chapter

Cite this chapter

Chandler, A.C. (1982). Malignant melanoma of the eye. In: Seigler, H.F. (eds) Clinical Management of Melanoma. Developments in Oncology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7493-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7493-7_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7495-1

  • Online ISBN: 978-94-009-7493-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics